In the high-stakes world of pharmaceuticals, generic drugs have become the unsung heroes of healthcare accessibility. These cost-effective alternatives to […]
The Regulatory Maze: How Generic Drugs Navigate FDA Approval Read Post »
In the high-stakes world of pharmaceutical innovation, drafting detailed drug patent claims is a critical process that can make or
In the ever-evolving world of pharmaceuticals, a controversial practice has emerged that’s causing quite a stir: biologic product hopping. But
Biologic Product Hopping: Innovation or Market Manipulation? Read Post »
Annual Drug Patent Expirations for WINLEVI Winlevi is a drug marketed by Sun Pharm and is included in one NDA.
New patent expiration for Sun Pharm drug WINLEVI Read Post »
Enantiomer Switching: A Pharmaceutical Strategy to Extend Drug Patents Enantiomer switching, also known as chiral switching, is a strategy employed
The Chiral Switch: A Pharmaceutical Tactic to Prolong Exclusivity Read Post »
Annual Drug Patent Expirations for RUBRACA Rubraca is a drug marketed by Zr Pharma and is included in one NDA.
New patent expiration for Zr Pharma drug RUBRACA Read Post »
In the rapidly evolving landscape of biosimilars, intellectual property (IP) strategy is paramount. Biosimilar manufacturers face unique challenges, including navigating
Cracking the Biosimilar Code: A Deep Dive into Effective IP Strategies Read Post »
Introduction The Patent Trial and Appeal Board (PTAB) is a crucial component of the United States Patent and Trademark Office
Understanding the Patent Trial and Appeal Board (PTAB) – A Comprehensive Overview Read Post »
Annual Drug Patent Expirations for CONTRAVE Contrave is a drug marketed by Nalpropion and is included in one NDA. It
New patent expiration for Nalpropion drug CONTRAVE Read Post »
Get fresh news and insights, drug patent expirations & more…
